Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Economic analysis and pharmaceutical policy

J Rovira1

  • 1Institut Universitari de Salut Publica-Departament de Teoria Economica, Universitat de Barcelona, Spain.

Anaesthesia
|October 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of microplastics and metal accumulation in domestic ducks (Anas platyrhynchos f. domesticus) of a contaminated reservoir in Central Mexico.

Marine pollution bulletin·2025
Same author

Non-linear models for black carbon exposure modelling using air pollution datasets.

Environmental research·2022
Same author

Reconstruction of phthalate exposure and DINCH metabolites from biomonitoring data from the EXHES cohort of Tarragona, Spain: A case study on estimated vs reconstructed DEHP using the PBPK model.

Environmental research·2020
Same author

Bisphenol A analogues (BPS and BPF) present a greater obesogenic capacity in 3T3-L1 cell line.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2020
Same author

Comparing dietary and non-dietary source contribution of BPA and DEHP to prenatal exposure: A Catalonia (Spain) case study.

Environmental research·2018
Same author

Association of Brain-Dead Donors' Terminal Inflammation With Delayed Graft Function in Kidney Transplant Recipients.

Transplantation proceedings·2017
Same journal

Management of major thoracic trauma: a narrative review.

Anaesthesia·2026
Same journal

Pulmonary artery catheters or central venous catheters for cardiac surgery: the PUMA Pilot randomised clinical trial.

Anaesthesia·2026
Same journal

Opioid-free vs. opioid-inclusive anaesthesia with or without regional anaesthesia for postoperative pain.

Anaesthesia·2026
Same journal

Optimal dose of intra-operative dexmedetomidine for postoperative delirium prevention: a reply.

Anaesthesia·2026
Same journal

Optimal dose of intra-operative dexmedetomidine for postoperative delirium prevention.

Anaesthesia·2026
Same journal

Pain control or brain protection with esketamine: a reply.

Anaesthesia·2026
See all related articles

Economic evaluation aids resource allocation by comparing costs and consequences. Despite evolving methodologies, its importance grows due to healthcare resource limitations.

Area of Science:

  • Health economics
  • Pharmaceutical policy analysis
  • Resource allocation strategies

Background:

  • Economic evaluation is crucial for rational decision-making in resource deployment.
  • Pharmaceutical policies often involve conflicting objectives from diverse social groups.
  • Limited resources in healthcare necessitate efficient allocation methods.

Purpose of the Study:

  • To highlight the role of economic evaluation in pharmaceutical policy.
  • To underscore the growing importance of economic analysis in healthcare decision-making.
  • To address the need for wider acceptance of new evaluation methodologies.

Main Methods:

  • Comparative analysis of alternative actions based on costs and consequences.
  • Review of existing economic evaluation frameworks in healthcare.

Related Experiment Videos

  • Assessment of resource limitations impacting healthcare providers and policymakers.

    • Main Results:

    • Economic evaluation provides a framework for rational resource deployment.
    • Pharmaceutical policy development is influenced by competing societal objectives.
    • Economic analysis is an increasingly vital tool for healthcare decision-makers.

    Conclusions:

    • Economic evaluation is essential for optimizing resource use in healthcare.
    • The complexity of pharmaceutical policy requires robust evaluation tools.
    • Despite challenges in methodology acceptance, economic analysis is indispensable due to resource constraints.